Advancing Metabolic Solutions for Chronic Disease
509(a)(2) Not for Profit Public Charity
At Hippocrates Research Foundation, we believe a durable remission—or cure—for cancer is within reach through metabolic interventions targeting mitochondrial dysfunction.
HRF at a Glance
The experts at Hippocrates Research Foundation have years of experience successfully reversing chronic diseases when standard of care medicine has failed. Most chronic diseases can be traced back to mitochondrial dysfunction and insufficient cellular energy production. The criteria for interventions at HRF is “First do no Harm.”
- 25+ Years of Medical Experience
- 27 Research Topics Covered
- 4 Active Case Studies
- 10+ Peer-Reviewed References
The Abscopal Effect Initiative
The abscopal effect, in which treatment of one tumor triggers the immune system to attack cancer throughout the body, represents one of the most promising pathways to lasting remission.
HRF emphasizes timing: optimizing the immune system before ablation increases systemic anti-cancer response likelihood. FDA-approved ablative technologies include Histotripsy, Pulsed Electric Field Therapy, and HIFU.
Our Research Focus Areas
- Histotripsy & Abscopal Effect — Non-invasive focused ultrasound technology that destroys tumors and can trigger systemic immune responses.
- Molecular Hydrogen Therapy — A powerful antioxidant small enough to enter and repair DNA found in mitochondria and cell nuclei.
- Deuterium Depletion — Lowering heavy hydrogen levels to improve cellular health and mitochondrial function.
- Press-Pulse Protocol — Non-toxic metabolic therapy based on Dr. Seyfried’s research targeting cancer cell fuel sources.
- Triple Anti-oxidant Therapy — Alpha-lipoic acid, silymarin, and selenium regimen showing promise in cancer and virus treatment.
- Tumor Markers & Liquid Biopsies — Advanced blood testing for early cancer detection and treatment monitoring.
Disease States We Address
Support Our Research
Your donation supports our mission to reverse chronic diseases through metabolic interventions targeting mitochondrial dysfunction.